Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 1, Pages 88-97
Publisher
Wiley
Online
2012-12-13
DOI
10.1002/ijc.27983
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesothelin-Targeted Agents in Clinical Trials and in Preclinical Development
- (2012) R. J. Kelly et al. MOLECULAR CANCER THERAPEUTICS
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro
- (2011) Motoki Miyazawa et al. CANCER LETTERS
- Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation
- (2011) U. Bharadwaj et al. CARCINOGENESIS
- Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine
- (2011) Basav N. Hangalapura et al. VACCINE
- Development of a method for effective amplification of human adenovirus 40
- (2010) Satoshi Yamasaki et al. ARCHIVES OF VIROLOGY
- Immunologic Basis of Vaccine Vectors
- (2010) Margaret A. Liu IMMUNITY
- Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity
- (2010) Lukas Flatz et al. NATURE MEDICINE
- Redundant and Synergistic Mechanisms Control the Sequestration of Blood-born Adenovirus in the Liver
- (2009) Nelson C Di Paolo et al. MOLECULAR THERAPY
- New Insights on Adenovirus as Vaccine Vectors
- (2009) Marcio O Lasaro et al. MOLECULAR THERAPY
- The cancer vaccine roller coaster
- (2009) Bruce Goldman et al. NATURE BIOTECHNOLOGY
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice
- (2009) Michael P Kim et al. Nature Protocols
- Epidemiology of pancreatic cancer: an overview
- (2009) Sara Raimondi et al. Nature Reviews Gastroenterology & Hepatology
- Liver Is Able to Activate Naïve CD8+ T Cells with Dysfunctional Anti-Viral Activity in the Murine System
- (2009) John R. Lukens et al. PLoS One
- Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3
- (2008) U. Bharadwaj et al. MOLECULAR CANCER RESEARCH
- Mesothelin Promotes Anchorage-Independent Growth and Prevents Anoikis via Extracellular Signal-Regulated Kinase Signaling Pathway in Human Breast Cancer Cells
- (2008) N. Uehara et al. MOLECULAR CANCER RESEARCH
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
- (2008) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now